Medication info
Venus Plus Tablet

Venus Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Bazedoxifene Acetate›22.6mg / 1 tabletCholecalciferol Concentrate Powder›8mg / 1 tablet
Manufacturer / importer
Korea Hyutex Pharmaceutical Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
30 tablets / PTP [10 tablets / PTPX3]
Approval status
Active

MFDS item code 201805296 · Approved 2018.12.26 · Insurance code 649104200

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults
Adult dose
Take 1 tablet once daily, regardless of food. If the patient's intake of calcium and vitamin D from food is inadequate, supplements should be taken. Patients with renal impairment: This medicine has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. Patients with hepatic impairment: The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, its use is not recommended.

Ingredients

Manufacturer
Korea Hyutex Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
  • Spinal Fractures
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women. It is particularly effective in reducing the occurrence of spinal fractures. However, its efficacy for non-spinal fractures has not yet been clearly established. Therefore, this medication helps manage osteoporosis by reducing the risk of spinal fractures.

How to take

Adult dose

Take 1 tablet once daily, regardless of food. If the patient's intake of calcium and vitamin D from food is inadequate, supplements should be taken. Patients with renal impairment: This medicine has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. Patients with hepatic impairment: The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, its use is not recommended.

Precautions

This medication may increase the risk of thrombosis in the blood. Particularly, the risk of venous thromboembolism such as deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis may be increased, so it is advised not to use it in women at high risk for such conditions. This medication is intended solely for use in postmenopausal women and is not recommended for premenopausal women since its safety has not been established. If abnormal symptoms such as uterine bleeding occur during use, it is essential to consult a healthcare professional. The safety of this medication has not been established in breast cancer patients, so it is advised not to use it for prevention or treatment purposes. Patients who are allergic to this medication or have hypersensitivity, a history of thrombosis, pregnant women, breastfeeding women, those with unexplained uterine bleeding, symptoms of endometrial cancer, hypercalcemia or hypercalciuria, kidney stone patients, and those with specific genetic issues such as lactose intolerance should not take this medication. Patients with hypertriglyceridemia, renal or hepatic dysfunction, restricted mobility, or those taking specific medications should use this medication with caution and follow the physician's instructions. During the administration of this medication, symptoms such as facial flushing or leg cramps may occur, and if there are any abnormal symptoms in the eyes, immediate consultation with a physician is required. If calcium intake is insufficient, calcium supplements should be taken, and patients at high risk of vitamin D deficiency may require additional vitamin D supplementation. Care should be taken while driving or operating machinery as drowsiness or visual disturbances may occur. Pregnant women or those who may become pregnant should not take this medication, and if pregnancy is confirmed while taking it, it should be discontinued immediately. In case of overdose, there is no specific antidote, so treatment should be symptomatic, particularly monitoring for symptoms of hypercalcemia due to excessive vitamin D intake. This medication is not for use in children, and while no special dosage adjustment is required for elderly patients, careful monitoring is necessary. Finally, this medication should be kept out of reach of children and stored in its original container.

Side effects

Hypersensitivity, drowsiness, retinal vein thrombus, facial flushing, deep vein thrombosis, superficial venous thrombophlebitis, pulmonary embolism, dry mouth, urticaria, rash, itching, muscle cramps, peripheral edema, increased serum triglycerides, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased vision, blurred vision, photopsia, visual field defect, visual impairment, dry eye syndrome, eyelid edema, eyelid twitching, eye pain, eye swelling, vomiting, gastritis, colon polyps, belching, fever, systemic edema, fatigue, death, fracture, myalgia, shoulder rotator cuff syndrome, spinal canal stenosis, cerebral infarction, cerebral hemorrhage, pyelonephritis, bradycardia, respiratory failure, biliary stone, allergic reaction, chest discomfort, leg pain, edema, facial swelling, altered temperature sensation, lethargy, weakness, lack of efficacy, dermatitis, localized skin reactions, increased sweating, eczema, hair loss, lower back pain, arthralgia, muscle weakness, headache, pharyngitis, palpitations, sputum disorders, cough, asthma, dyspnea, laryngitis, pleural effusion, increased alkaline phosphatase, liver cyst, hepatocellular damage, weight gain, hyperlipidemia, central obesity, urinary difficulties, urinary abnormalities, renal cyst, urinary incontinence, vaginal bleeding, breast congestion, insomnia, leukocytosis, laceration, contusion, psychological symptoms, altered consciousness, headache, decreased appetite, weight loss, increased thirst, arrhythmia, increased urination, kidney stones, renal calcifications, calcification in the outer tissues of the bone, myalgia, arthralgia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is between 1 to 30 degrees Celsius. This will help maintain the effectiveness of the medication over time.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets / PTP [10 tablets / PTPX3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.